Your browser doesn't support javascript.
loading
Prenatal diagnosis of a case with SEA-HPFH deletion thalassemia with whole HBB gene deletion.
Ly Thi Thanh, Ha; Le Thi Thanh, Huong; Hoang Luong, Long; Huy Tran, Thinh; Liu, Su-Ching; Truong, Hai Nam; Ta, Thanh Van; Bui, The-Hung; Tran, Van Khanh.
Affiliation
  • Ly Thi Thanh H; Department of Genomics and Stem Cell Engineering, Vinmec International Hospital, Hanoi, Viet Nam.
  • Le Thi Thanh H; Department of Genomics and Stem Cell Engineering, Vinmec International Hospital, Hanoi, Viet Nam.
  • Hoang Luong L; Center for Gene-Protein Research, Hanoi Medical University, Hanoi, Viet Nam.
  • Huy Tran T; Center for Gene-Protein Research, Hanoi Medical University, Hanoi, Viet Nam.
  • Liu SC; China Medical University Hospital, Taichung City, Taiwan.
  • Truong HN; Institute of Biotechnology, Vietnam Academy of Science and Technology, Hanoi, Viet Nam.
  • Ta TV; Center for Gene-Protein Research, Hanoi Medical University, Hanoi, Viet Nam.
  • Bui TH; Center for Gene-Protein Research, Hanoi Medical University, Hanoi, Viet Nam; Karolinska Institutet, Department of Molecular Medicine, Clinical Genetics Unit, Karolinska University Hospital, Stockholm, Sweden.
  • Tran VK; Center for Gene-Protein Research, Hanoi Medical University, Hanoi, Viet Nam. Electronic address: tranvankhanh@hmu.edu.vn.
Taiwan J Obstet Gynecol ; 57(3): 435-441, 2018 Jun.
Article in En | MEDLINE | ID: mdl-29880180
ABSTRACT

OBJECTIVE:

The thalassemias is a group of hereditary disorders with impaired production of functional hemoglobin. In this report we described a rare case of compound heterozygous mutation of South-East Asia type hereditary persistence of fetal hemoglobin (SEA-HPFH) and ß -thalassemia that allowed prenatal diagnosis to be performed in a subsequent pregnancy in the family. CASE REPORT The father showed a SEA-HPFH thalassemia trait phenotype, while his genotype revealed that he was heterozygous for the SEA-HPFH deletion; The mother genotype was heterozygote for IVS-II-654 mutation; the second child had co-inherited both parental mutations and was, thus, a compound heterozygote for ß-thalassemia (IVS-II-654)/SEA-HPFH deletion. His phenotype was intermediate ß-thalassemia. Prenatal genotyping of a fetal sample during the third pregnancy confirmed the fetus was only heterozygote for SEA-HPFH deletion and the parents elected to continue the pregnancy.

CONCLUSION:

We described the clinical and molecular characterization of the first detected case of compound ß-Thalassemia/SEA-HPFH deletion in Northern Vietnam. The report also highlighted the accuracy and necessity of mutation screening for families with thalassemia to inform accurate genetic counseling and targeted prenatal diagnosis when desired.
Subject(s)
Key words

Full text: 1 Database: MEDLINE Main subject: Prenatal Diagnosis / Fetal Hemoglobin / Gene Deletion / Beta-Thalassemia Type of study: Diagnostic_studies Limits: Child, preschool / Female / Humans / Male / Newborn / Pregnancy Country/Region as subject: Asia Language: En Journal: Taiwan J Obstet Gynecol Journal subject: GINECOLOGIA / OBSTETRICIA Year: 2018 Type: Article

Full text: 1 Database: MEDLINE Main subject: Prenatal Diagnosis / Fetal Hemoglobin / Gene Deletion / Beta-Thalassemia Type of study: Diagnostic_studies Limits: Child, preschool / Female / Humans / Male / Newborn / Pregnancy Country/Region as subject: Asia Language: En Journal: Taiwan J Obstet Gynecol Journal subject: GINECOLOGIA / OBSTETRICIA Year: 2018 Type: Article